Andrew G.Jack (Drew)

Associate

Columbus + 1.614.281.3679

Connect:

Share

Drew Jack focuses his practice on the representation of clients in the health care industry in connection with transactional and regulatory matters. His experience includes developing hospital-physician alignment strategies; guiding clients through strategic transactions, including hospital mergers and acquisitions and joint venture arrangements; working with health care providers to develop clinically integrated provider networks and accountable care organizations; drafting innovative medical staff bylaws and related medical staff documents; structuring integrated delivery system transactions; and counseling clients on health care fraud and abuse issues, including compliance with the Stark Law, Anti-Kickback Statute, and Civil Monetary Penalties Law. Additionally, Drew has worked with clients in the life sciences industry in connection with multijurisdictional clinical trials and research collaborations.

Drew has assisted in the formation and operations of more than a dozen clinically integrated networks as well as accountable care organizations participating in the Medicare Shared Savings Program (MSSP) "Pathways to Success." He regularly advises on related corporate governance, payer/provider contracting, and regulatory issues, including application of the fraud and abuse waivers available under the MSSP, and has developed hospital quality and efficiency program arrangements.

Drew is a member of the Ohio State Bar Association and the American Health Lawyers Association (AHLA) and is a vice chair for the AHLA's Transactions Affinity Group. He also is a member of the Columbus Office's Hiring Committee and Diversity, Inclusion & Advancement Committee.

Experience

  • Sumitomo Dainippon Pharma acquires late stage biopharma companies and forms alliance with Roivant Sciences Ltd. worth $3 billionJones Day advised Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo") in an acquisition of late stage biopharma companies and formation of alliance with Roivant Sciences Ltd.
  • AKSM receives $550,000 investmentJones Day represented AKSM Ltd., a Columbus-based medical company, in connection with a $550,000 investment from undisclosed investors.
  • AKSM involved in joint ventures with urologists regarding lithotripsy, radiation therapy, and related urologic proceduresJones Day has been assisting American Kidney Stone Management, Ltd. ("AKSM"), a leading national lithotripsy provider, with joint venture syndication work relating to lithotripsy, as well as most ancillary urology related lines of business.
  • COUG enters into ASC, radiation therapy, lithotripsy, and other urological ventures as largest single specialty urology practice in OhioJones Day assisted Central Ohio Urology Group, the largest lithotripsy supergroup in Ohio, with the formation of an IMRT/IGRT enterprise and the later sale of a majority stake in that enterprise to a third party.
  • ProMedica Health Network accepted in Medicare Shared Savings ProgramJones Day advised ProMedica Health Network, an affiliate of ProMedica Health System, in connection with its successful application for participation in the Medicare Shared Savings Program.
  • ProMedica signs Academic Affiliation Agreement with University of ToledoJones Day represented ProMedica, one of Ohio's largest health systems and a mission-based, not-for-profit healthcare organization, in negotiations with the University of Toledo and its College of Medicine & Life Sciences to develop a premier academic medical center with an emphasis on teaching, research, and the use of technology and evidence-based medicine, for the purpose of enhancing the recruitment and retention of high-quality faculty, students, residents, fellows, and allied health professionals in the region.
  • Jefferies finances AMAG Pharmaceuticals' acquisition of Cord Blood Registry®Jones Day advised Jefferies Finance LLC, as administrative agent, collateral agent, joint lead arranger and joint bookrunner, and Jefferies LLC, as representative of the initial purchasers, in connection with the $850 million in financing provided to AMAG Pharmaceuticals, Inc., a specialty pharmaceutical company with a focus on maternal health, anemia, and cancer supportive care, to finance a portion of its acquisition of Cord Blood Registry® (CBR®), a large stem cell collection and storage company.
  • Palos Community Hospital builds clinical affiliation with Loyola University Medical CenterJones Day assisted Palos Community Hospital in creating an innovative clinical affiliation with Loyola University Medical Center based in Illinois.
  • Bon Secours signs joint venture with Westchester Medical CenterJones Day advised Bon Secours Health System, Inc. ("BSHSI"), a Catholic health system sponsored by Bon Secours Ministries with multiple hospitals and facilities across six states, and its subsidiary, Bon Secours Charity Health System, Inc. ("BSCHS"), a three-hospital health system north of New York City, with respect to the sale of its controlling interest in BSCHS to, and the creation of an ongoing joint venture arrangement with, Westchester Medical Center ("WMC").
  • ProMedica Health System forms ProMedica Health Network, Inc.Jones Day advised ProMedica Health System on the formation and structuring of ProMedica Health Network Inc., an accountable care organization and clinically integrated network established for the purposes of promoting greater accountability for the quality, effectiveness and efficiency of health care delivered to communities throughout the States of Ohio and Michigan.
  • RockWood Equity Partners affiliate acquires Altimate MedicalJones Day advised an affiliate of RockWood Equity Partners LLC in connection with its acquisition and related financing of Altimate Medical, Inc., a manufacturer of sit-to-stand assistive devices used in patient rehabilitation, from Invacare Corporation, a manufacturer and distributor of innovative home and long-term care medical products.
  • Bon Secours St. Mary's Hospital accepted to participate in Medicare Bundled Payments for Care Improvement programJones Day assisted Bon Secours St. Mary's Hospital in connection with the development of a bundled payment program for lower extremity joint replacements (knee and hip revisions) and the hospital's successful application for participation in Model 2 of the Medicare Bundled Payments for Care Improvement program.
    • View All

    January 2020 Newsletters

    Vital Signs: Digital Health Law Update | Winter 2020

    June 2017 Commentaries

    "Meaningfully Useful" Risk Mitigation Strategies for Providers Following the eClinicalWorks Settlement

    December 2015 Commentaries

    CMS Makes Changes to the Stark Law: Addressing Payment Reform, Reducing Burden, and Facilitating Compliance

    November 2015 Commentaries

    CMS and OIG Issue Final Fraud and Abuse Waivers in Connection with the Medicare Shared Savings Program

    May 2015 Commentaries

    Congress Amends Gainsharing Civil Monetary Penalties and Commissions Further Study of Gainsharing Arrangements

    April 2015 Commentaries

    HHS Announces Next Generation ACO Model of Payment and Care Delivery

    March 2015 Alerts

    Provider Preparedness in the Wake of CoOportunity Health's Liquidation

    October 2014 Alerts

    CMS Announces New Initiative Designed to Support Clinicians in Developing Comprehensive Quality Improvement Strategies

    Speaking Engagements

    • December 4, 2015
      Overview of Key Fraud and Abuse and Medicare Program Payment Waivers, PACT Population Health Collaborative (Webcast)
    • February 11, 2015
      Key Health Law Issues for Non-Healthcare Lawyers, Ohio State Bar Association (Webcast)
    • December 9, 2014
      Key Health Law Issues for Non-Healthcare Lawyers, Jones Day CLE Academy
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.